Objective: To examine the predictors of time-to-premature gonadal failure (PGF) in SLE patients from LUMINA, a multiethnic US cohort.
Methods: PGF was defined as per the SLICC Damage Index (SDI). Factors associated with time-to-PGF occurrence were examined by univariable and multivariable [three models according to cyclophosphamide use, at T0 (model 1), over time (model 2) and the total number of intravenous pulses (model 3)] Cox proportional hazards regression analyses.
Results: Thirty-seven of 316 women (11.7%) developed PGF (19 Hispanic-Texans, 14 African Americans, four Caucasians and no Hispanic-Puerto Ricans). By multivariable analyses, older age at T0 (HR=1.10 to 1.14; 95% CI 1.02 to 1.05-1.19 to 1.23) and disease activity (SLAM-R) in all models (HR=1.22 to 1.24; 95% CI 1.10 to 1.12-1.35 to 1.37), Hispanic-Texan ethnicity in models 2 and 3 (HR=4.06 to 5.07; 95% CI 1.03 to 1.25-15.94 to 20.47) and cyclophosphamide use in models 1 and 3 (1-6 pulses) (HR=4.01 to 4.65; 95% CI 1.55 to 1.68-9.56 to 13.94) were predictors of a shorter time-to-PGF.
Conclusions: Disease activity and Texan-Hispanic ethnicity emerged as predictors of a shorter time-to-PGF while the associations with cyclophosphamide use and older age were confirmed. Furthermore, cyclophosphamide induction therapy emerged as an important determinant of PGF.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.